What is the incidence of ankylosing spondylitis (AS) in females?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Ankylosing Spondylitis in Females

The incidence of ankylosing spondylitis (AS) in females is approximately 3 cases per 100,000 person-years across all age groups, which is significantly lower than the 12 cases per 100,000 person-years observed in males. 1

Epidemiological Data

  • The female-to-male ratio for AS incidence is approximately 1:4, with AS being traditionally considered more common in males 1

  • Age-specific incidence rates in females vary by age group:

    • 0-15 years: 1 per 100,000
    • 16-24 years: 4 per 100,000
    • 25-44 years: 5 per 100,000
    • 45-64 years: 3 per 100,000
    • 65-74 years: 1 per 100,000
    • 75 years: 0 per 100,000 1

  • In contrast, males show higher incidence rates across all age groups, with peak incidence of 23 per 100,000 in the 25-44 age group 1

Recent Research Challenging Traditional Ratios

  • Recent evidence suggests the gender disparity may be less pronounced than previously thought:

    • A 2023 study of US Army personnel found similar incidence rates between males and females (incidence rate ratio 1.16, p=0.23) 2
    • This study suggests that previous observations of male predominance may have been influenced by:
      • Clinic populations less representative of US race/ethnicity distribution
      • Disease ascertainment tools that identified subjects later in disease course
      • Lack of organized screenings for musculoskeletal symptoms 2
  • Historical data from 1975 revealed that when screening HL-A W27 (HLA-B27) positive individuals, the prevalence of AS was similar in both sexes, suggesting underdiagnosis in females 3

Clinical Presentation Differences by Gender

  • Female AS patients often present with:

    • Higher disease activity scores (BASDAI, ASDAS)
    • More tender entheses
    • Worse physical function and quality of life 4
  • Male AS patients typically present with:

    • More kyphosis
    • Greater spinal radiographic damage
    • Higher rates of radiographic progression during treatment 4
  • These differences may contribute to delayed or missed diagnosis in females, as the classic radiographic findings may develop more slowly or be less pronounced 5

Diagnostic Considerations

  • Early detection of AS in females requires attention to characteristic clinical features:

    • Onset before age 30
    • Night pain and morning stiffness
    • Intermittent, migratory joint pain
    • Decreased spine mobility
    • Sacroiliac tenderness 5
  • HLA-B27 testing is useful for detecting early and mild forms of AS, with over 90% of patients testing positive regardless of gender 5

  • Radioisotope scanning can detect early inflammation of sacroiliac joints before changes are evident on standard radiographs, which may be particularly important for female patients 5

Clinical Implications

  • The lower reported incidence in females may lead to underdiagnosis and delayed treatment 5
  • Early identification is crucial as proper management may prevent severe fixed deformities of the spine and root joints 6
  • Female patients may require more frequent monitoring as they switch TNF-α inhibitors more often than males (32% vs. 14%) despite showing comparable clinical improvement during treatment 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.